Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine pharmacodynamic sedation study for pediatric transthoracic echocardiography
ChiCTR1900022180Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in Cardiovascular Malformation (CVM), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: heart rate, oxygen saturation and 1 more. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR1900022180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022180.